IMVT Financials

Immunovant Inc - Financial statements & key metrics

Stock Price

$26.55

Market Cap

$5.11B

EPS

$-2.67

Income Statement Highlights

Most Recent Quarter: 2025-03-31

Revenue

Gross Profit

Operating Income

Net Income

$-413.84M

EPS (Diluted)

$-2.73

Balance Sheet Highlights

Total Assets

$776.22M

Total Liabilities

$68.78M

Shareholders Equity

Cash & Equivalents

$713.97M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-375.87M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.7%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is IMVT revenue?

View IMVT's income statement for detailed revenue data.

Is IMVT profitable?

IMVT reported a loss of $413.84M in the most recent quarter.

What is IMVT market cap?

IMVT has a market capitalization of $5.11B, making it a mid-cap stock.

Does IMVT have debt?

View IMVT's balance sheet for debt information.

What is IMVT cash flow?

Cash flow data is available in the full financial statements.